Nexalin Technology (NXL) Change in Receivables (2021 - 2026)
Nexalin Technology's (NXL) quarterly Change in Receivables came in at -$755.0 in Q1 2026, down 172.6% year-on-year from $1040.0 in Q1 2025, and down 102.11% quarter-over-quarter from $35833.0 in Q4 2025.
Nexalin Technology (NXL) Change in Receivables (2021 - 2026) Analysis & Trends
Nexalin Technology's Change in Receivables history runs 6 years deep, the most recent figure standing at -$755.0 for Q1 2026.
- On a quarterly basis, Change in Receivables fell 172.6% year-over-year to -$755.0 in Q1 2026; TTM through Mar 2026 was $31927.0, a 406.62% increase from a year earlier, with the FY2025 full-year figure at $33722.0, changed N/A from the prior year.
- Change in Receivables slipped to -$755.0 in Q1 2026 per NXL's latest filing, from $35833.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $53540.0 in Q1 2022 and bottomed at -$51916.0 in Q3 2025.
- The 5-year median for Change in Receivables is $30.5 (2023), against an average of $2428.5.
- Biggest YoY gain for Change in Receivables was 9314.09% in 2025; the steepest drop was 1171.76% in 2025.
- Year by year, Change in Receivables stood at -$5477.0 in 2022, then slumped by 59.36% to -$8728.0 in 2023, then soared by 155.5% to $4844.0 in 2024, then surged by 639.74% to $35833.0 in 2025, then tumbled by 102.11% to -$755.0 in 2026.
- Per Business Quant, the three latest NXL Change in Receivables figures stand at -$755.0 (Q1 2026), $35833.0 (Q4 2025), and -$51916.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nexalin Technology | 9.32 Mn | 6.61 Mn | 13,133.00 | -755.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -755.00 |
| Mar 31, 2026 | -755.00 |
| Dec 31, 2025 | 35,833.00 |
| Dec 31, 2025 | 35,833.00 |
| Sep 30, 2025 | -51,916.00 |
| Sep 30, 2025 | -51,916.00 |
| Jun 30, 2025 | 48,765.00 |
| Jun 30, 2025 | 48,765.00 |
| Mar 31, 2025 | 1,040.00 |
| Mar 31, 2025 | 1,040.00 |
| Sep 30, 2024 | 4,844.00 |
| Sep 30, 2024 | 4,844.00 |
| Jun 30, 2024 | 518.00 |
| Jun 30, 2024 | 518.00 |
| Mar 31, 2024 | -100.00 |
| Mar 31, 2024 | -100.00 |
| Dec 31, 2023 | -8,728.00 |
| Dec 31, 2023 | -8,728.00 |
| Sep 30, 2023 | 161.00 |
| Sep 30, 2023 | 161.00 |